Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Volker Laux

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Cardiovascular Research|June 17, 2011
A role for coagulation factor Xa in experimental pulmonary arterial hypertensionMartina Delbeck, Katrin F Nickel, Elisabeth Perzborn, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 22, 2022
Lecanoric acid mediates anti-proliferative effects by an M phase arrest in colon cancer cellsLuise A Roser, Pelin Erkoc, Rebecca Ingelfinger, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Novel factor Xa inhibitors based on a 2-carboxyindole scaffold: SAR of P4 substituents in combination with a neutral P1 ligandMarc Nazaré, Melanie Essrich, David W Will, et al.
Life (Basel, Switzerland)|August 27, 2021
Characterization of ACE Inhibitors and AT<sub>1</sub>R Antagonists with Regard to Their Effect on ACE2 Expression and Infection with SARS-CoV-2 Using a Caco-2 Cell ModelPhilipp Reus, Ann-Kathrin Schneider, Thomas Ulshöfer, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Factor Xa inhibitors based on a 2-carboxyindole scaffold: SAR of neutral P1 substituentsMarc Nazaré, Melanie Essrich, David W Will, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|June 25, 2017
Androgen inhibits key atherosclerotic processes by directly activating ADTRP transcriptionChunyan Luo, Elisabeth Pook, Bo Tang, et al.
Journal of Medicinal Chemistry|July 8, 2005
Probing the subpockets of factor Xa reveals two binding modes for inhibitors based on a 2-carboxyindole scaffold: a study combining structure-activity relationship and X-ray crystallographyMarc Nazaré, David W Will, Hans Matter, et al.
Bioorganic & Medicinal Chemistry Letters|May 6, 2004
Novel factor Xa inhibitors based on a benzoic acid scaffold and incorporating a neutral P1 ligandMarc Nazaré, Hans Matter, Otmar Klingler, et al.
Immunotargets and Therapy|November 7, 2024
Identification of CRTH2 as a New PPARγ-Target Gene in T Cells Suggested CRTH2 Dependent Conversion of T<sub>h</sub>2 Cells as Therapeutic Concept in COVID-19 InfectionAntonia Becker, Karoline Röhrich, Amanda Leske, et al.
Ebiomedicine|September 13, 2020
Comprehensive platelet phenotyping supports the role of platelets in the pathogenesis of acute venous thromboembolism - results from clinical observation studiesMarina Panova-Noeva, Bianca Wagner, Markus Nagler, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Cardiovascular Research|June 17, 2011
A role for coagulation factor Xa in experimental pulmonary arterial hypertensionMartina Delbeck, Katrin F Nickel, Elisabeth Perzborn, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 22, 2022
Lecanoric acid mediates anti-proliferative effects by an M phase arrest in colon cancer cellsLuise A Roser, Pelin Erkoc, Rebecca Ingelfinger, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Novel factor Xa inhibitors based on a 2-carboxyindole scaffold: SAR of P4 substituents in combination with a neutral P1 ligandMarc Nazaré, Melanie Essrich, David W Will, et al.
Life (Basel, Switzerland)|August 27, 2021
Characterization of ACE Inhibitors and AT<sub>1</sub>R Antagonists with Regard to Their Effect on ACE2 Expression and Infection with SARS-CoV-2 Using a Caco-2 Cell ModelPhilipp Reus, Ann-Kathrin Schneider, Thomas Ulshöfer, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Factor Xa inhibitors based on a 2-carboxyindole scaffold: SAR of neutral P1 substituentsMarc Nazaré, Melanie Essrich, David W Will, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|June 25, 2017
Androgen inhibits key atherosclerotic processes by directly activating ADTRP transcriptionChunyan Luo, Elisabeth Pook, Bo Tang, et al.
Journal of Medicinal Chemistry|July 8, 2005
Probing the subpockets of factor Xa reveals two binding modes for inhibitors based on a 2-carboxyindole scaffold: a study combining structure-activity relationship and X-ray crystallographyMarc Nazaré, David W Will, Hans Matter, et al.
Bioorganic & Medicinal Chemistry Letters|May 6, 2004
Novel factor Xa inhibitors based on a benzoic acid scaffold and incorporating a neutral P1 ligandMarc Nazaré, Hans Matter, Otmar Klingler, et al.
Immunotargets and Therapy|November 7, 2024
Identification of CRTH2 as a New PPARγ-Target Gene in T Cells Suggested CRTH2 Dependent Conversion of T<sub>h</sub>2 Cells as Therapeutic Concept in COVID-19 InfectionAntonia Becker, Karoline Röhrich, Amanda Leske, et al.
Ebiomedicine|September 13, 2020
Comprehensive platelet phenotyping supports the role of platelets in the pathogenesis of acute venous thromboembolism - results from clinical observation studiesMarina Panova-Noeva, Bianca Wagner, Markus Nagler, et al.
Pageof 4